<DOC>
	<DOCNO>NCT02415439</DOCNO>
	<brief_summary>The purpose study examine safety , tolerability , PK various increase single multiple dos VBP15 healthy adult subject .</brief_summary>
	<brief_title>A Phase 1 Single Ascending Dose Multiple Ascending Dose Study Evaluate Safety , Tolerability , Pharmacokinetics VBP15 Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>For Single Ascending Dose Study ( SAD ) : Male subject , age 18 65 year , inclusive . For Multiple Ascending Dose Study ( MAD ) : Male subject female subject nonchildbearing potential age 18 65 , inclusive . For MAD Study : Women childbearing potential . Clinically significant abnormal laboratory parameter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>adult</keyword>
	<keyword>volunteer</keyword>
</DOC>